| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Dina M Abd El-Khalik, Eman A Hafez, Hanan E Hassan, Asmaa E Mahmoud, Doaa Maamoun Ashour, Nashwa A Morshed. Nail Folds Capillaries Abnormalities Associated With Type 2 Diabetes Mellitus Progression and Correlation With Diabetic Retinopathy. Clinical medicine insights. Endocrinology and diabetes. vol 15. 2022-09-22. PMID:36131849. |
diabetic retinopathy (dr) is an important microvascular consequence of long-term type 2 diabetes mellitus (t2dm), and it can lead to blindness if not properly diagnosed and managed. |
2022-09-22 |
2023-08-14 |
Not clear |
| Kangjia Lv, Hui Ying, Guangyi Hu, Jing Hu, Qizhi Jian, Fang Zhan. Integrated multi-omics reveals the activated retinal microglia with intracellular metabolic reprogramming contributes to inflammation in STZ-induced early diabetic retinopathy. Frontiers in immunology. vol 13. 2022-09-19. PMID:36119084. |
diabetic retinopathy (dr) is the leading cause of visual impairment and blindness among working-age people. |
2022-09-19 |
2023-08-14 |
mouse |
| Wen Shi, Zhishang Meng, Jing Lu. Connexin 43 (Cx43) regulates high-glucose-induced retinal endothelial cell angiogenesis and retinal neovascularization. Frontiers in endocrinology. vol 13. 2022-09-19. PMID:36120455. |
diabetic retinopathy (dr) is an important microvascular complication of type 1 and type 2 diabetes mellitus (dm) and a major cause of blindness. |
2022-09-19 |
2023-08-14 |
human |
| Lindan Wei, Xin Sun, Chenxi Fan, Rongli Li, Shuanglong Zhou, Hongsong Y. The pathophysiological mechanisms underlying diabetic retinopathy. Frontiers in cell and developmental biology. vol 10. 2022-09-16. PMID:36111346. |
diabetic retinopathy (dr) is the most common complication of diabetes mellitus (dm), which can lead to visual impairment and even blindness in severe cases. |
2022-09-16 |
2023-08-14 |
Not clear |
| Mohamed Tawfik, Fang Chen, Jeffrey L Goldberg, Bernhard A Sabe. Nanomedicine and drug delivery to the retina: current status and implications for gene therapy. Naunyn-Schmiedeberg's archives of pharmacology. 2022-09-15. PMID:36107200. |
retinal disorders, including age-related macular degeneration (amd), diabetic retinopathy (dr), and glaucoma, are the leading causes of blindness. |
2022-09-15 |
2023-08-14 |
Not clear |
| Swara M Sarvepalli, Beth A Bailey, David D'Alessio, Madleen Lemaitre, Anne Vambergue, Jay Rathinavelu, Majda Hadziahmetovi. Risk factors for the development or progression of diabetic retinopathy in pregnancy: Meta-analysis and systematic review. Clinical & experimental ophthalmology. 2022-09-13. PMID:36098625. |
diabetic retinopathy (dr) is the leading cause of blindness in the working-age population, and it increases in severity during pregnancy. |
2022-09-13 |
2023-08-14 |
Not clear |
| Jannah Waled Hassan, Ashay D Bhatwadeka. Senolytics in the treatment of diabetic retinopathy. Frontiers in pharmacology. vol 13. 2022-09-12. PMID:36091769. |
dr is characterized by damage to retinal vasculature resulting in vision impairment and, if untreated, could eventually lead to blindness. |
2022-09-12 |
2023-08-14 |
Not clear |
| Ahmed Mohamud Yusuf, Rebecca Claire Lusobya, John Mukisa, Charles Batte, Damalie Nakanjako, Otiti Juliet-Senger. Validity of smartphone-based retinal photography (PEEK-retina) compared to the standard ophthalmic fundus camera in diagnosing diabetic retinopathy in Uganda: A cross-sectional study. PloS one. vol 17. issue 9. 2022-09-06. PMID:36067194. |
diabetic retinopathy (dr) is one of the major complications of diabetes mellitus and is a significant cause of blindness worldwide. |
2022-09-06 |
2023-08-14 |
Not clear |
| Lihua Li, Kaibo Yang, Cong Li, Han Zhang, Honghua Yu, Kang Chen, Xiaohong Yang, Lei Li. Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetes. Frontiers in immunology. vol 13. 2022-09-05. PMID:36059453. |
diabetic retinopathy (dr) is a common microvascular complication of diabetes mellitus (dm) and is one of the leading causes of blindness among dm patients. |
2022-09-05 |
2023-08-14 |
human |
| Hangqi Shen, Qiaoyun Gong, Jingting Zhang, Haiyan Wang, Qinghua Qiu, Jingfa Zhang, Dawei Lu. TRIM46 aggravated high glucose-induced hyper permeability and inflammatory response in human retinal capillary endothelial cells by promoting IκBα ubiquitination. Eye and vision (London, England). vol 9. issue 1. 2022-09-05. PMID:36064447. |
diabetic retinopathy (dr) as a severe diabetic complication contributes to blindness. |
2022-09-05 |
2023-08-14 |
human |
| Haiyan Li, Xiaofang Dong, Wei Shen, Fuhua Ge, Hongsong L. Resampling-based cost loss attention network for explainable imbalanced diabetic retinopathy grading. Computers in biology and medicine. vol 149. 2022-09-04. PMID:36058067. |
diabetic retinopathy (dr) is currently considered to be one of the most common diseases that cause blindness. |
2022-09-04 |
2023-08-14 |
Not clear |
| Rana Sorkhabi, Mohammad Hossein Ahoor, Amir Ghorbani Haghjo, Elnaz Tabei, Nazli Taher. Assessment of tear inflammatory cytokines concentration in patients with diabetes with varying severity of involvement. Experimental eye research. 2022-09-04. PMID:36058266. |
diabetic retinopathy (dr), as one of the most important causes of blindness in western societies, is a common micro-vasculopathy associated with diabetes. |
2022-09-04 |
2023-08-14 |
Not clear |
| Nurbadriah Binti Jasmiad, Rohana Binti Abd Ghani, Renu Agarwal, Zaliha Binti Ismail, Azlindarita Aisyah Mohd Abdullah, Mohd Yusri Idoru. Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy. BMC ophthalmology. vol 22. issue 1. 2022-09-03. PMID:36057550. |
diabetic retinopathy (dr) is a serious complication of longstanding type 2 diabetes mellitus (t2dm), a leading cause of blindness and visual disability in the world. |
2022-09-03 |
2023-08-14 |
Not clear |
| Lei Liu, Mengmeng Wang, Guocheng Li, Qi Wan. Construction of Predictive Model for Type 2 Diabetic Retinopathy Based on Extreme Learning Machine. Diabetes, metabolic syndrome and obesity : targets and therapy. vol 15. 2022-09-01. PMID:36046759. |
the common cause of blindness in people with type 2 diabetes (t2d) is diabetic retinopathy (dr). |
2022-09-01 |
2023-08-14 |
Not clear |
| Qiaoling Song, Yuchao Zhang, Minghui Zhang, Xiaoli Ma, Qianyue Zhang, Chenyang Zhao, Zhongwen Zhang, Huichen Zhao, Wenchao Hu, Xinxin Zhang, Xiwen Ren, Ming An, Jinbo Yang, Yuantao Li. Identifying gene variants underlying the pathogenesis of diabetic retinopathy based on integrated genomic and transcriptomic analysis of clinical extreme phenotypes. Frontiers in genetics. vol 13. 2022-08-29. PMID:36035153. |
diabetic retinopathy (dr) is a common complication and the leading cause of blindness in patients with type 2 diabetes. |
2022-08-29 |
2023-08-14 |
Not clear |
| Tingyu Qin, Xiangying Xi, Zhipeng W. Downregulation of glycoprotein non-metastatic melanoma protein B prevents high glucose-induced angiogenesis in diabetic retinopathy. Molecular and cellular biochemistry. 2022-08-29. PMID:36036335. |
diabetic retinopathy (dr), a microvascular complication characterized by abnormal angiogenesis, is the most common reason for irreversible blindness. |
2022-08-29 |
2023-08-14 |
human |
| Jiahui Ren, Shuxia Zhang, Yunfeng Pan, Meiqi Jin, Jiaxin Li, Yun Luo, Xiaobo Sun, Guang L. Diabetic retinopathy: Involved cells, biomarkers, and treatments. Frontiers in pharmacology. vol 13. 2022-08-26. PMID:36016568. |
diabetic retinopathy (dr), a leading cause of vision loss and blindness worldwide, is caused by retinal neurovascular unit dysfunction, and its cellular pathology involves at least nine kinds of retinal cells, including photoreceptors, horizontal and bipolar cells, amacrine cells, retinal ganglion cells, glial cells (müller cells, astrocytes, and microglia), endothelial cells, pericytes, and retinal pigment epithelial cells. |
2022-08-26 |
2023-08-14 |
Not clear |
| Jinglan Li, Xuanlong Li, Mingxing Lei, Wanyue Li, Wenqian Chen, Tianju Ma, Yi Gao, Zi Ye, Zhaohui L. A prediction model for worsening diabetic retinopathy after panretinal photocoagulation. Diabetology & metabolic syndrome. vol 14. issue 1. 2022-08-26. PMID:36028852. |
as one of the severe complications of diabetes mellitus, diabetic retinopathy (dr) is the leading cause of blindness in the working age worldwide. |
2022-08-26 |
2023-08-14 |
Not clear |
| Eli Pradhan, Dipak Nag, Deepanee Wewalwala, Subash Pokharel, Dolores Conroy, Divya Pradhan. SAARC Academy of Ophthalmology - Tailoring Clinical Standards for Diabetic Retinopathy Care to Available Resources. Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH. vol 14. issue 27. 2022-08-23. PMID:35996912. |
diabetic retinopathy (dr), is one of the major causes of blindness and visual impairment. |
2022-08-23 |
2023-08-14 |
Not clear |
| Chaoqun Liu, Yue Ren, Xin Sui, Kaiyang Liu, Jianing Zhang, Zian Wang, Yingying Li, Yanling Zhan. Integrating network pharmacology, transcriptomics, and molecular simulation to reveal the mechanism of tert-butylhydroquinone for treating diabetic retinopathy. European journal of pharmacology. 2022-08-20. PMID:35987258. |
diabetic retinopathy (dr), a common microvascular complication of diabetes mellitus, is a significant cause of blindness. |
2022-08-20 |
2023-08-14 |
Not clear |